KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Finished Goods (2018 - 2025)

Historic Finished Goods for LifeMD (LFMD) over the last 8 years, with Q3 2025 value amounting to $2.7 million.

  • LifeMD's Finished Goods rose 6650.32% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year increase of 6650.32%. This contributed to the annual value of $1.6 million for FY2024, which is 1812.65% down from last year.
  • Per LifeMD's latest filing, its Finished Goods stood at $2.7 million for Q3 2025, which was up 6650.32% from $2.5 million recorded in Q2 2025.
  • Over the past 5 years, LifeMD's Finished Goods peaked at $2.8 million during Q2 2022, and registered a low of $1.0 million during Q2 2024.
  • Its 5-year average for Finished Goods is $1.9 million, with a median of $1.8 million in 2021.
  • In the last 5 years, LifeMD's Finished Goods skyrocketed by 25996.82% in 2021 and then tumbled by 5706.48% in 2024.
  • Over the past 5 years, LifeMD's Finished Goods (Quarter) stood at $1.6 million in 2021, then soared by 62.46% to $2.6 million in 2022, then fell by 26.61% to $1.9 million in 2023, then dropped by 18.13% to $1.6 million in 2024, then skyrocketed by 70.75% to $2.7 million in 2025.
  • Its last three reported values are $2.7 million in Q3 2025, $2.5 million for Q2 2025, and $2.2 million during Q1 2025.